Arkolith/Insider Trading/BDTX/Form 4

Biotech Growth N V

10% OwnerBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Jun 29, 2023
Net Buying
Open-Market Buys
$9.6M
Open-Market Sells
$0
Net Open-Market Flow
$9.6M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2023Buy(P)1.7M$5.49$9.6M7.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-016705) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML